Status:
COMPLETED
ENGAGE: Virtual Reality-based Psychotherapy for Negative Symptoms in Schizophrenia
Lead Sponsor:
Mental Health Services in the Capital Region, Denmark
Collaborating Sponsors:
CNSR, Glostrup Psychiatric Center
Conditions:
Schizophrenia Spectrum Disorders
Negative Symptoms in Schizophrenia
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
The primary goal of this pilot study is to examine the feasibility and acceptability of a new Virtual Reality-based intervention against negative symptoms in schizophrenia spectrum disorders (SSD). T...
Detailed Description
Negative symptoms (NS) are core features of schizophrenia and strongly correlated with vocational and social outcomes, quality of life, and have a higher impact on later outcome than positive symptoms...
Eligibility Criteria
Inclusion
- ICD-10 diagnosis of a schizophrenia-spectrum disorder (F2x)
- Negative symptom score of ≥3 on the SANS items avolition or anhedonia
Exclusion
- Diagnosis of organic brain disease
- Intellectual disability (IQ \< 70)
- Current diagnosis of drug dependency
- Command of spoken Danish or English inadequate for engaging in therapy
- Refusing to be informed on incidental findings on the MRI scans
Key Trial Info
Start Date :
December 9 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 7 2026
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06993831
Start Date
December 9 2024
End Date
January 7 2026
Last Update
January 9 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Copenhagen Research Center for Mental Health (CORE), Mental Health Services CPH, Denmark
Hellerup, Greater Copenhagen, Denmark, 2900